TRANSCAN-3 advances personalized T-cell therapies for esophageal cancer with progress in neoantigen discovery and T-cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback